G. Boons

Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies

M. Peeters, G. Van Camp, K. Op de Beeck, 2019, Reviews in Endocrine and Metabolic Disorders.

Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-up

K. Janssens, M. Peeters, G. Roeyen, 2021, Clinical Cancer Research.

Hotspot DAXX, PTCH2 and CYFIP2 mutations in pancreatic neuroendocrine neoplasms.

P. Pauwels, M. Peeters, K. Biermann, 2019, Endocrine-related cancer.

PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis

C. Print, D. Peeters, M. Peeters, 2020, Cancers.

Cell-Free DNA From Metastatic Pancreatic Neuroendocrine Tumor Patients Contains Tumor-Specific Mutations and Copy Number Variations

K. Janssens, M. Peeters, G. Roeyen, 2018, Front. Oncol..